0

Mps1-IN-3

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATIAR4244092
Molecular Weight537.63
InChI KeyOFRMASLPWOMYHN-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorlight yellow to dark yellow
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Effects of the Selective MPS1 Inhibitor MPS1-IN-3 on Glioblastoma Sensitivity to Antimitotic Drugs

Bakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, Nicholas Kwiatkowski, Jinhua Wang, Wenjun Zhou, Almuth F Kessler, Grant Lewandrowski, Lotte Hiddingh, Nik Sol, Tonny Lagerweij, Laurine Wedekind, etc.

J Natl Cancer Inst. 2013 Sep 4;105(17):1322-31.

PMID: 23940287

1

Effects of Tumor Treating Fields (TTFields) on Glioblastoma Cells Are Augmented by Mitotic Checkpoint Inhibition

Almuth F Kessler, Greta E Frömbling, Franziska Gross, Mirja Hahn, Wilfrid Dzokou, Ralf-Ingo Ernestus, Mario Löhr, Carsten Hagemann

Cell Death Discov. 2018 Jul 16;4:12.

PMID: 30210815

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode